Melinta Therapeutics, Inc. (NASDAQ: MLNT) is a commercial-stage pharmaceutical company dedicated to meeting the continually evolving threat of bacterial infections by discovering, developing and commercializing a continual stream of novel antibiotics to provide new therapeutic options.